Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06668584
Title	A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients with IDH1-mutated Myeloid Malignancies
Recruitment	Not yet recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	acute myeloid leukemia chronic myelomonocytic leukemia myelodysplastic/myeloproliferative neoplasm myelodysplastic syndrome
Therapies	Olutasidenib
Age Groups:	senior \| adult
Covered Countries	USA